Advertisement

Picture Campus Berlin-Buch GmbH BBC BerlinBioCube Start-up Center 650x100px

News > All

Total search results: 6897 | Ordered by Date (descending)
1 2 3 ... 67 68 69  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Oxford Biomedica plc. (11/22/22). "Press Release: Oxford Biomedica Appoints Dr Frank Mathias as Chief Executive Officer". Oxford. 2022-11-22
Catalym GmbH. (11/22/22). "Press Release: Catalym Closes EUR 50 Million Series C Financing to Expand and Accelerate Phase 2 Clinical Development of Visugromab in Patients with Solid Tumors". Oxford. 2022-11-22
FogPharma (Fog Pharmaceuticals Inc.). (11/21/22). "Press Release: FogPharma Announces $178 Million Series D Financing to Advance Pipeline of First-in-Class Helicon Polypeptide Therapeutics Targeting Major Cancer Drivers". Cambridge, MA. 2022-11-21
Sarcura GmbH. (11/17/22). "Press Release: Sarcura Secures € 7M Seed Plus Funding to Revolutionize Cell Therapy Manufacturing". Klosterneuburg. 2022-11-17
Cradle Bio B.V.. (11/17/22). "Press Release: Biotech Startup Cradle Exits Stealth, Raises $5.5M to Design Protein-machines and Cell-factories with AI". 2022-11-17
Valneva S.E.. (11/17/22). "Press Release: Valneva Appoints Dipal Patel as Chief Commercial Officer". Saint-Herblain. 2022-11-17
Novigenix S.A.. (11/16/22). "Press Release: Novigenix Announces First Closing of Its $20M Series B". Lausanne. 2022-11-16
Jnana Therapeutics Inc.. (11/15/22). "Press Release: Jnana Therapeutics Announces Second Collaboration with Roche to Address Challenging-to-Drug Targets in Cancer, Immune-Mediated and Neurological Diseases". Boston, MA. 2022-11-15
Jnana Therapeutics Inc.. (11/15/22). "Press Release: Jnana Therapeutics Raises $107 Million to Advance Lead PKU Program and Progress Therapeutics Pipeline Discovered by the RAPID Platform". Boston, MA. 2022-11-15
Bruker Corporation. (11/14/22). "Press Release: Bruker Announces Agreement to Acquire Neurescence Inc., Bolstering Neuroscience Research Portfolio". Billerica, MA. 2022-11-14
Air Liquide Healthcare. (11/14/22). "Press Release: Air Liquide Healthcare Federates Its Biobanking Activity under the Name BioKryo and Inaugurates Its New Site in Germany". Bagneux. 2022-11-14
BC Platforms AG. (11/8/22). "Press Release: BC Platforms Announces USD 20 Million Growth Financing Led by Jolt Capital". 2022-11-08
Bruker Corporation. (11/8/22). "Press Release: Bruker Announces Acquisition of Inscopix for Neuroscience Research". Mountain View, CA. 2022-11-08
Bruker Corporation. (11/7/22). "Press Release: Bruker Corporation to Participate in the 2022 Jefferies London Healthcare Conference". Billerica, MA. 2022-11-07
Affimed N.V.. (11/3/22). "Press Release: Affimed and Artiva Biotherapeutics Announce Partnership to Advance Combination Therapy of Innate Cell Engager (ICE) AFM13 and Off-the-Shelf Allogeneic NK Cell Therapy AB-101". Heidelberg & San Diego, CA. 2022-11-03
Centogene N.V.. (11/3/22). "Press Release: Centogene Launches Rare and Neurodegenerative Disease Biodata Network". Cambridge, MA, Rostock & Berlin. 2022-11-03
Exscientia plc. (11/3/22). "Press Release: Exscientia Expands Biologics Design Capability with Automated Laboratory". Oxford. 2022-11-03
Bayer AG. (11/3/22). "Press Release: Leaps by Bayer Leads Investment Round in AgTech Pioneer NuCicer to Bring Unique and Cost-effective Plant-protein Ingredients to Market by 2023". Davis, CA & Leverkusen. 2022-11-03
Affimed N.V.. (11/1/22). "Press Release: Affimed to Present at the 2022 Jefferies London Healthcare Conference". Heidelberg. 2022-11-01
Memo Therapeutics AG. (11/1/22). "Press Release: Memo Therapeutics AG and Ono Pharmaceutical Enter Antibody Discovery Partnership for Immuno-oncology Targets". Schlieren. 2022-11-01
ASC Oncology GmbH. (11/1/22). "Press Release: ASC Oncology Proudly Announces New Partnership with Tamer Group". Berlin. 2022-11-01
ADC Therapeutics S.A.. (11/1/22). "Press Release: ADC Therapeutics Appoints Kristen Harrington-Smith as Chief Commercial Officer and Peter Graham as Chief Legal Officer". Lausanne. 2022-11-01
Evotec SE. (10/28/22). "Press Release: Evotec, CDP Venture Capital and Angelini Ventures Launch Translational Partnership »Extend« with Leading Italian Academic Institutions". Hamburg. 2022-10-28
MorphoSys AG. (10/27/22). "Press Release: GSK, MorphoSys’ Licensing Partner, Provides Update on ContRAst Phase III Program for Otilimab in Moderate to Severe Rheumatoid Arthritis". Planegg. 2022-10-27
Medicines Discovery Catapult (MDC). (10/26/22). "Press Release: Medicines Discovery Catapult Appoints International Entrepreneur Volker Hirsch to Bolster Commercial Expertise". 2022-10-26
Kizoo Technology Capital GmbH. (10/26/22). "Press Release: Kizoo Invests in Rejuvenation Startup MoglingBio". Berlin & Ulm. 2022-10-26
Evotec SE. (10/25/22). "Press Release: Evotec Enters Partnership with Hannover Medical School to Create Molecular Patient Database in Autoimmune Diseases". Hamburg. 2022-10-25
Alto Neuroscience Inc.. (10/25/22). "Press Release: Alto Neuroscience Announces $35 Million Series B Financing". Los Altos, CA. 2022-10-25
Resolve Biosciences GmbH. (10/25/22). "Press Release: Resolve Biosciences Appoints Chief Commercial Officer to Drive Worldwide Adoption of Molecular Cartography Workflow". Monheim. 2022-10-25
Proteros Biostructures GmbH. (10/25/22). "Press Release: Proteros and Adrestia Initiate Multi-target Partnership to Discover First-in-class Drugs for Intractable Genetic Diseases". Martinsried. 2022-10-25
Resolve Biosciences GmbH. (10/24/22). "Press Release: Resolve Biosciences Secures $71 Million Series B Financing to Accelerate Commercial Expansion to Meet Global Demand for Molecular Cartography Workflow". Monheim. 2022-10-24
Hookipa Pharma Inc.. (10/20/22). "Press Release: Hookipa Announces Strategic Collaboration and License Agreement with Roche to Develop Novel Arenaviral Immunotherapy for KRAS-mutated Cancers". New York, NY & Vienna. 2022-10-20
FyoniBio GmbH. (10/20/22). "Press Release: FyoniBio and Strike Pharma Sign a Master Service Agreement Covering Cell Line Development for a Novel Bi-specific Therapeutic mAb". Berlin & Stockholm. 2022-10-20
HMNC Holding GmbH. (10/20/22). "Press Release: HMNC Brain Health Raises EUR 14.3 million to Advance Precision Psychiatry Therapies". Munich. 2022-10-20
Boehringer Ingelheim. (10/20/22). "Press Release: University of Tübingen and Boehringer Ingelheim Join Forces to Lead AI and Data Science R&D for New Medical Breakthroughs". Tübingen & Ingelheim. 2022-10-20
Nucleome Therapeutics Ltd.. (10/19/22). "Press Release: Nucleome Therapeutics Raises oversubscribed £37.5 Million Series A Financing to Decode the Dark Matter of the Human Genome and Deliver First-in-Class Precision Medicines". Oxford. 2022-10-19
Celeris Therapeutics GmbH. (10/19/22). "Press Release: Celeris Therapeutics to Receive 12.5 Million Euros in Funding from the European Innovation Council". Graz. 2022-10-19
Empyrean Neuroscience, Inc.. (10/18/22). "Press Release: Empyrean Neuroscience Launches with $22M Series A and Genetic Engineering Platform to Advance Pipeline of Neuroactive Compounds Targeting CNS Disorders". New York, NY & Cambridge. 2022-10-18
Anokion S.A.. (10/18/22). "Press Release: Anokion Announces $35 Million Equity Investment from Pfizer". Cambridge, MA & Lausanne. 2022-10-18
Co.don AG. (10/17/22). "Pressemitteilung: Vereinbarung über die Veräußerung des Geschäftsbetriebs". Teltow & Leipzig. 2022-10-17
BioM Biotech Cluster Development GmbH. (10/12/22). "Press Release: Osaka and Munich Continue Their Cuccessful Partnership". 2022-10-12
Wacker Chemie AG. (10/12/22). "Press Release: Neuway Pharma and Wacker Launch Research Project to Develop RNA-Based Actives for the Treatment of Central Nervous System Diseases". Munich & Bonn. 2022-10-12
Apollo Health Ventures. (10/11/22). "Press Release: Apollo Health Ventures and Paul Scherrer Institute Launch Focal Biosciences". Boston, MA, Berlin & Villigen. 2022-10-11
Immunic, Inc.. (10/10/22). "Press Release: Immunic, Inc. Announces $60.0 Million Oversubscribed Private Placement Equity Financing". New York, NY. 2022-10-10
Immatics N.V.. (10/10/22). "Press Release: Immatics Reports Interim Clinical Data Update on ACTengine IMA203 TCR-T Monotherapy Targeting PRAME". Houston, TX & Tübingen. 2022-10-10
Andera Partners. (10/10/22). "Press Release: Andera Partners Raises Its Largest Life Sciences Fund at €456M, Demonstrating the Attractiveness of Its Activity and of the Sector". Paris. 2022-10-10
Immatics N.V.. (10/10/22). "Press Release: Immatics Announces $110 Million Underwritten Offering of Ordinary Shares". Houston, TX & Tübingen. 2022-10-10
IZB Martinsried. (10/7/22). "Press Release: Munich Life Science Pitch Day at the IZB. Eleven Teams Presented to 28 Life Science Investors with an Available Investment Volume of more than 20 Billion Euros". Martinsried. 2022-10-07
High-Tech Gründerfonds Management GmbH. (10/6/22). "Press Release: Real-Time Monitoring of Bioprocesses. Irubis Closes EUR 2.8m Seed Round Led by HTGF, Verve Ventures and Ventura BioMed Investors". Munich. 2022-10-06
Terraplasma GmbH. (10/6/22). "Press Release: Election of an Advisory Board for Terraplasma. Extensive Industry Expertise". Garching. 2022-10-06
T-Curx GmbH. (10/6/22). "Press Release: T-Curx GmbH, a German CAR-T Cell Biotech Spin-Off from University of Würzburg, Appoints Ulf Grawunder as CEO". Würzburg. 2022-10-06
BioRiver – Life Science im Rheinland e.V.. (10/5/22). "Press Release: Three Disruptive Approaches in Biotechnology and Medicine Win the BioRiver Boost! 2022 Biotech Start-up Competition". Düsseldorf & Hilden. 2022-10-05
HeartBeat.bio AG. (10/5/22). "Press Release: HeartBeat.bio Collaborates with Boehringer Ingelheim to Investigate Cardiac Organoids for the Development of New Treatments for People with Heart Diseases". Vienna. 2022-10-05
Araris Biotech AG. (10/4/22). "Press Release: Araris Biotech Closes $24 Million Financing Round". Zurich. 2022-10-04
Valneva S.E.. (10/4/22). "Press Release: Valneva Announces Closing of Upsized €102.9 Million Global Offering". Saint-Herblain. 2022-10-04
Sibylla Biotech S.p.A.. (10/4/22). "Press Release: Sibylla Biotech Raises €23 Million Series A to Advance Protein Degradation by Folding Interference Pipeline and Expand Technology Platform". Verona. 2022-10-04
Aurobac Therapeutics S.A.S.. (10/4/22). "Press Release: Aurobac Therapeutics, the Joint Venture Recently Created by Boehringer Ingelheim, Evotec and bioMérieux, Appoints Florence Séjourné as Chief Executive Officer". Lyon. 2022-10-04
BioM Biotech Cluster Development GmbH. (9/30/22). "Press Release: Prof. Ralf Huss Appointed as New Managing Director of BioM Biotech Cluster Development GmbH". 2022-09-30
Xund Solutions GmbH. (9/29/22). "Press Release: Healthtech Start-up Xund Raises €6m – One of the Largest Seed Rounds to Date in Austria". 2022-09-29
Pureos Partners AG. (9/28/22). "Press Release: Pureos Partners Welcomes Dr. Veronica Gambillara Fonck as New Partner to Its Investment Team". Pfäffikon. 2022-09-28
High-Tech Gründerfonds Management GmbH. (9/28/22). "Press Release: GS Bavaria Closes Seven-figure Seed Round for Scaling Tungsten Particles as Sustainable Additive in Composites". 2022-09-28
BRAIN Biotech AG. (9/27/22). "Press Release: Change in the Executive Management Board of BRAIN Biotech AG, Genome Editing Activities Established Under the Akribion Genomics brand". Zwingenberg. 2022-09-27
NLC Ventures Netherlands B.V.. (9/27/22). "Press Release: BioDGraft, an NLC Venture, Sets Out to Eliminate the Need for Vein Harvesting in Bypass Surgeries, Proposing a Solution that Lasts for Life". 2022-09-27
Navigo Proteins GmbH. (9/26/22). "Press Release: Navigo and Mannin Sign Agreement to Develop Innovative Affinity Ligand Against a Novel Drug for the Treatment of COVID-19". Halle (Saale). 2022-09-26
Kupando GmbH. (9/26/22). "Press Release: Kupando Raises €13 Million in Series A Funding Round". Schönefeld. 2022-09-26
c-LEcta GmbH. (9/23/22). "Press Release: OFB Starts Construction Work for »BioSquare Leipzig« Technology Campus". 2022-09-23
Merck KGaA. (9/21/22). "Press Release: Merck Enters Collaboration and Option to License Agreement with Nerviano Medical Sciences to Develop Next-Generation PARP1 Selective Inhibitor [ Not intended for US- or Canada- and UK-based media ]". Darmstadt. 2022-09-21
Adapsyn Bioscience Inc.. (9/21/22). "Press Release: Adapsyn Bioscience Enters into Strategic Collaboration with Evotec". Hamilton, ON. 2022-09-21
Hedera Dx S.A.. (9/21/22). "Press Release: Hedera Dx Raises €14 Million in Seed Funding to Accelerate Global Adoption of Liquid Biopsies". Lausanne. 2022-09-21
Merck KGaA. (9/21/22). "Press Release: Merck Opens New € 29 Million Biologics Testing Center in Shanghai". Shanghai. 2022-09-21
ECBF Management GmbH. (9/20/22). "Press Release: ECBF Leads €10m Series B Investment in Digital Pest Monitoring Provider Trapview to Expand Its Sustainable Agriculture Technology Portfolio". Luxembourg. 2022-09-20
Nuvisan ICB GmbH. (9/20/22). "Press Release: Nuvisan Receives US$ 9.6m Grant for a Multi-target Drug Discovery Program on Novel Non-hormonal Contraceptive Medicines". Berlin. 2022-09-20
Avelo AG. (9/20/22). "Press Release: Avelo Closes CHF 2.2 Million Oversubscribed Seed Round". 2022-09-20
Evotec SE. (9/20/22). "Press Release: Just – Evotec Biologics Awarded Contract from the U.S. Department of Defense under Accelerated Antibodies Program". Hamburg. 2022-09-20
Scailyte AG. (9/19/22). "Press Release: Scailyte Closes Series A Funding with a CHF 6 Million Investment". 2022-09-19
Genfit S.A.. (9/19/22). "Press Release: Genfit to Acquire Clinical-stage Biopharmaceutical Company Versantis, Expanding Its Portfolio in Liver Diseases". Lille & Cambridge, MA. 2022-09-19
Evotec SE. (9/16/22). "Press Release: Evotec Initiates Ground-breaking for New Biologics Facility J.POD Toulouse, France (EU)". Hamburg. 2022-09-16
Tridek-One S.A.S.. (9/15/22). "Press Release: Tridek-One Closes a €16 Million Financing Round to Develop First-in-Class Immune Checkpoint Agonists". Paris. 2022-09-15
T-Curx GmbH. (9/15/22). "Press Release: Caroline Burger, PhD, Appointed as T-Curx' Global Head Business Development". Würzburg. 2022-09-15
Tricares S.A.S.. (9/15/22). "Press Release: Tricares Raises €47m in a First Closing of Its Series C Financing to Fund Further Development of Minimally Invasive Treatment for Tricuspid Regurgitation". Paris & Munich. 2022-09-15
Kuros Biosciences AG. (9/15/22). "Press Release: Kuros Biosciences Announces Successful CHF 6.0 Million Private Placement (Ad-hoc announcement pursuant to Article 53 of the SIX listing rules)". Schlieren. 2022-09-15
Aignostics GmbH. (9/15/22). "Press Release: Aignostics Raises €14m Series A to Advance AI-powered Pathology". Berlin. 2022-09-15
Forever Healthy Foundation gGmbH. (9/15/22). "Press Release: Rejuvenation Startup Summit 2022 Announces Program and Speakers". 2022-09-15
Capstan Therapeutics, Inc.. (9/14/22). "Press Release: Capstan Therapeutics Launches with $165 Million to Deliver on the Clinical Promise of Precise In Vivo Cell Engineering". San Diego, CA & Philadelphia, PA. 2022-09-14
Scienion AG. (9/13/22). "Press Release: Scienion and Cellenion Launch the proteoCHIP LF 48, for Label-free Single-cell Proteomics Sample Preparation on the cellenONE platform". Berlin & Lyon. 2022-09-13
HeartBeat.bio AG. (9/12/22). "Press Release: HeartBeat.bio and Molecular Devices Announce Collaboration to Automate and Scale Cardiac Organoids for High-throughput Screening in Drug Discovery". Vienna & San José, CA. 2022-09-12
Immatics N.V.. (9/10/22). "Press Release: Immatics Presents Comprehensive Preclinical Data Set for TCR Bispecific Candidate IMA402 Targeting PRAME at European Society for Medical Oncology (ESMO) Congress 2022". Houston, TX & Tübingen. 2022-09-10
Heidelberg Pharma AG. (9/9/22). "Press Release: Heidelberg Pharma Announces Conclusion of License Agreement with Partner Takeda To Develop an Antibody Targeted Amanitin Conjugate". Ladenburg. 2022-09-09
genOway S.A.. (9/8/22). "Press Release: Sigma-Aldrich and genOway Expand Their CRISPR/Cas9 Strategic Alliance". St. Louis, MO & Lyon. 2022-09-08
faCelliate GmbH. (9/7/22). "Press Release: faCellitate, a BASF Spin-off, Closes a €3.7m Seed Round Led by Sarstedt and HTGF". Mannheim. 2022-09-07
Indivumed GmbH. (9/7/22). "Press Release: Indivumed and CellPhenomics Announce Partnership for Improved Cancer Patient Care". Berlin & Hamburg. 2022-09-07
QLi5 Therapeutics GmbH. (9/7/22). "Press Release: QLi5 Therapeutics Attracts EUR 10 Million in Series A Financing". Dortmund. 2022-09-07
PhoreMost Ltd.. (9/6/22). "Press Release: PhoreMost Enters Multi-project Drug Target Discovery Collaboration with Roche". Cambridge. 2022-09-06
Nodus Oncology Ltd.. (9/6/22). "Press Release: Nodus Oncology Announces Acquisition of Basilea Pharmaceutica’s PARG Inhibitor Programme". Edinburgh. 2022-09-06
Emergence Therapeutics AG. (9/6/22). "Press Release: Emergence Therapeutics Licenses Synaffix ADC Technology Platform in $360M Deal". Amsterdam & Duisburg. 2022-09-06
ADC Therapeutics S.A.. (9/6/22). "Press Release: ADC Therapeutics to Participate in Morgan Stanley’s 20th Annual Global Healthcare Conference". Lausanne. 2022-09-06
Nodus Oncology Ltd.. (9/6/22). "Press Release: Nodus Oncology Launches, Founded by Cumulus Oncology and in Partnership with the Lead Discovery Center, to Focus on Developing First and Best-in-Class Molecules Inhibiting Novel DNA Damage Response Targets". 2022-09-06
EMBL. (9/6/22). "Press Release: ERC Proof-of-Concept Grant Provides Way to Realise Commercial Potential of ‘SpaceM’ Technology". 2022-09-06
Arcensus GmbH. (9/5/22). "Press Release: Dammam Valley/KSA to Acquire the Majority of Arcensus GmbH/Germany to Accelerate the Global implementation of Whole Genome Sequencing in Genetic Diagnostics and Delivery of Breakthrough Technologies in Genomic Bio 2022-09-05
Boehringer Ingelheim. (9/2/22). "Press Release: U.S. FDA Approves First Treatment Option for Generalized Pustular Psoriasis Flares in Adults". Ingelheim. 2022-09-02
1 2 3 ... 67 68 69  next pagenext page



Advertisement

Picture [iito] Männer Ballett 650x100px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture EBD Group Biotech Showcase 2023 San Francisco 650x300px

» top